<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Titan Biotech Ltd has filed a disclosure confirming it does not qualify as a 'Large Corporate' under SEBI's Chapter XII framework for the financial year ending March 31, 2026. The company reports nil outstanding borrowings as per the SEBI circular definition. This is a routine regulatory compliance filing where the company must confirm its status annually. The disclosure is signed by the Compliance Officer and CFO, dated April 28, 2026.
Neutral for shareholders. The company simply confirms it falls below the Large Corporate threshold, which may indicate relatively low debt levels. No immediate impact on stock price expected from this filing.